Issue 29, 2018, Issue in Progress
From the journal:

RSC Advances

Correction: Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro

Nathan A. Fletchera  and  Melissa D. Krebs ORCID logo *a  

* Corresponding authors

a Department of Chemical and Biological Engineering, Colorado School of Mines, 1613 Illinois Street, Golden, CO 80401, USA
E-mail: mdkrebs@mines.edu

Abstract

Correction for ‘Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro’ by Nathan A. Fletcher et al., RSC Adv., 2018, 8, 8999–9005.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C8RA90033G
Article type
Correction
Submitted
23 Apr 2018
Accepted
23 Apr 2018
First published
01 May 2018
This article is Open Access
Creative Commons BY license

RSC Adv., 2018,8, 16043-16043

Permissions

Request permissions

Correction: Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro

N. A. Fletcher and M. D. Krebs, RSC Adv., 2018, 8, 16043 DOI: 10.1039/C8RA90033G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements